The Global AI for Drug Discovery and Development Market Size is estimated to register 35.1% growth over the forecast period from 2023 to 2030.

AI for Drug Discovery and Development Market Overview

The market is driven by the integration of diverse data types, including genomics, proteomics, metabolomics, and clinical data. NLP is extensively used to extract valuable information from scientific literature, clinical notes, and research articles. In areas like pathology and medical imaging, deep learning algorithms are utilized to analyze and interpret images. Growing collaborations between pharmaceutical companies, biotech firms, and AI technology providers are notable trends. In the AI for Drug Discovery market, software holds the largest market share.

Market dynamics

Market trend: The extensive integration of Natural Language Processing (NLP) for literature mining stands out as a pivotal force propelling the AI for Drug Discovery and Development Market.

The widespread adoption of Natural Language Processing (NLP) for literature mining emerges as a driving force that significantly propels the AI for Drug Discovery and Development Market. NLP technologies are extensively applied to extract valuable information from vast repositories of scientific literature, clinical notes, and research articles. Researchers and professionals in drug discovery leverage NLP to efficiently sift through extensive literature, identify key patterns, and extract pertinent data that can inform their work. This streamlined process accelerates literature review and knowledge extraction, allowing researchers to stay abreast of the latest advancements and discoveries in the field.

Market driver: The application of deep learning in pathology and medical imaging serves as a driving force shaping the AI for Drug Discovery and Development Market.

The utilization of deep learning in pathology and medical imaging drives the AI for Drug Discovery and Development Market by providing powerful tools for disease identification, drug efficacy assessment, and accurate diagnostic processes. As the demand for advanced and efficient solutions in these areas continues to grow, the integration of deep learning technologies becomes increasingly pivotal in shaping the landscape of AI-driven drug discovery and development. By analyzing medical images, these algorithms can provide insights into how drugs impact physiological conditions, helping researchers understand the effectiveness of potential treatments.

Market opportunity: Growing collaboration in the AI for Drug Discovery and Development Market stands out as a pivotal driver shaping the industry.

Increased collaboration in the AI for Drug Discovery and Development Market is a driving force that transforms the landscape by fostering innovation, leveraging sector-specific expertise, and expediting the integration of AI technologies. As these collaborative efforts become more prevalent, the market is poised to experience accelerated advancements in drug discovery and development, ultimately benefiting patients and healthcare outcomes. Furthermore, these partnerships enable the sharing of resources, knowledge, and risks. Pharmaceutical and biotech companies can leverage the specialized skills of AI technology providers without the need for substantial in-house investments in AI infrastructure and expertise.

Market share analysis: Drug Design presently commands the largest market share in the AI for Drug Discovery and Development domain.

Drug Design currently holds the largest market share among Target Identification, Molecule Screening, Drug Design, Preclinical, and Clinical Testing, AI algorithms can effectively predict the physical and chemical properties of potential drug candidates, aiding in the selection of promising compounds with the desired characteristics, such as activity, selectivity, and pharmacokinetics. AI can assist in optimizing the molecular structure of drug candidates to enhance their activity, selectivity, and other desirable properties, leading to more effective and targeted therapies. AI-powered tools can significantly accelerate the drug design process by automating tasks, identifying potential pitfalls early on, and providing rapid feedback on design modifications.

Machine Learning presently commands the largest market share in the AI for Drug Discovery and Development domain.

Machine Learning holds the largest market share among the mentioned technologies, accounting for approximately 40% of the global AI market. Machine Learning is a broad field that encompasses a wide range of techniques, making it adaptable to a vast array of tasks and problems. Machine Learning has found applications in a wide range of industries, including healthcare, finance, manufacturing, retail, and transportation. Machine Learning is a well-established field with a large body of research and development. This maturity has led to the development of robust and reliable algorithms. Many Machine Learning libraries and tools are available, making it easier for developers to implement Machine Learning solutions.

AI for Drug Discovery and Development Market Segmentation

By Type

Target Identification
Molecule Screening
Drug Design
Preclinical and Clinical Testing

By Indication

Immuno-oncology
Neurodegenerative diseases
Cardiovascular diseases
Metabolic diseases
Others

By Technology

Machine Learning
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Others

By End User

Pharmaceuticals
Biotechnology Companies
Research Organizations
Others

By Region

North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Others)
Asia Pacific (China, India, Japan, South Korea, Australia, Others)
Latin America (Brazil, Argentina, Others)
Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

Natural Language Processing and Recognition companies

NVIDIA Corporation (United States)
Microsoft Corporation (United States)
Exscientia (United Kingdom)
Google (United States)
Schrödinger (United States)
BenevolentAI (United Kingdom)
NuMedi (United States)
Atomwise Inc (United States)
Insilico Medicine (United States)
BERG LLC (United States)
Cloud Pharmaceuticals (United States)
Cyclica (Canada)
Deep Genomics (Canada)
IBM (United States)
BIOAGE (United States)V
alo Health (United States)
Iktos (France)
Evaxion Biotech (Denmark)
BenchSci (Canada)
Envisagenics (United States)
Owkin Inc (United States)
Biovista (United States)
Standing (South Korea)
twoXAR (United States)
XtalPi (United States)
Verge Genomics (United States)

*List not exhaustive

AI for Drug Discovery and Development Market Outlook 2023

1 Market Overview

1.1 Introduction to the AI for Drug Discovery and Development Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

2 Executive Summary

2.1 2023 AI for Drug Discovery and Development Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global AI for Drug Discovery and Development Market Companies with Area Served

4.2.2 Products Offerings Global AI for Drug Discovery and Development Market

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

6 Global AI for Drug Discovery and Development Market Trends

6.1 Global AI for Drug Discovery and Development Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global AI for Drug Discovery and Development Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global AI for Drug Discovery and Development Revenue (USD Million) and CAGR (%) by regions (2018-2030)

7 Global AI for Drug Discovery and Development Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global AI for Drug Discovery and Development Revenue (USD Million) by Type (2018-2022)

7.1.1 Global AI for Drug Discovery and Development Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global AI for Drug Discovery and Development Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global AI for Drug Discovery and Development Revenue (USD Million), Market Share (%) by Applications (2018-2022)

8 Global AI for Drug Discovery and Development Development Regional Status and Outlook

8.1 Global AI for Drug Discovery and Development Revenue (USD Million) By Regions (2018-2022)

8.2 North America AI for Drug Discovery and Development Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America AI for Drug Discovery and Development Revenue (USD Million) by Country (2018-2022)

8.2.2 North America AI for Drug Discovery and Development Revenue (USD Million) by Type (2018-2022)

8.2.3 North America AI for Drug Discovery and Development Revenue (USD Million) by Applications (2018-2022)

8.3 Europe AI for Drug Discovery and Development Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe AI for Drug Discovery and Development Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe AI for Drug Discovery and Development Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe AI for Drug Discovery and Development Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) by Applications (2018-2022)

8.5 South America AI for Drug Discovery and Development Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America AI for Drug Discovery and Development Revenue (USD Million), by Country (2018-2022)

8.5.2 South America AI for Drug Discovery and Development Revenue (USD Million) by Type (2018-2022)

8.5.3 South America AI for Drug Discovery and Development Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) by Applications (2018-2022)

9 Company Profiles

10 Global AI for Drug Discovery and Development Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global AI for Drug Discovery and Development Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global AI for Drug Discovery and Development Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global AI for Drug Discovery and Development Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global AI for Drug Discovery and Development Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

11 Global AI for Drug Discovery and Development Development Regional Status and Outlook Forecast

11.1 Global AI for Drug Discovery and Development Revenue (USD Million) By Regions (2023-2030)

11.2 North America AI for Drug Discovery and Development Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America AI for Drug Discovery and Development Revenue (USD) Million by Country (2023-2030)

11.2.2 North America AI for Drug Discovery and Development Revenue (USD Million), by Type (2023-2030)

11.2.3 North America AI for Drug Discovery and Development Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe AI for Drug Discovery and Development Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe AI for Drug Discovery and Development Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe AI for Drug Discovery and Development Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe AI for Drug Discovery and Development Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million), by Applications (2023-2030)

11.5 South America AI for Drug Discovery and Development Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America AI for Drug Discovery and Development Revenue (USD Million), by Country (2023-2030)

11.5.2 South America AI for Drug Discovery and Development Revenue (USD Million), by Type (2023-2030)

11.5.3 South America AI for Drug Discovery and Development Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million), by region (2023-2030)

11.6.2 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million), by Applications (2023-2030)

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global AI for Drug Discovery and Development Market Companies with Areas Served

Table 3 Products Offerings Global AI for Drug Discovery and Development Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global AI for Drug Discovery and Development Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global AI for Drug Discovery and Development Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global AI for Drug Discovery and Development Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Table 11 Global AI for Drug Discovery and Development Revenue Market Share (%) By Type (2018-2022)

Table 12 Global AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Table 13 Global AI for Drug Discovery and Development Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global AI for Drug Discovery and Development Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global AI for Drug Discovery and Development Market Share (%) By Regions (2018-2022)

Table 16 North America AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Table 17 North America AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Table 18 North America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Table 20 Europe AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Table 21 Europe AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Table 25 South America AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Table 26 South America AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Table 27 South America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Table 33 Global AI for Drug Discovery and Development Revenue Market Share (%) By Type (2023-2030)

Table 34 Global AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Table 35 Global AI for Drug Discovery and Development Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global AI for Drug Discovery and Development Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America AI for Drug Discovery and Development Revenue (USD)By Country (2023-2030)

Table 38 North America AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Table 39 North America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Table 41 Europe AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Table 42 Europe AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Table 46 South America AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Table 47 South America AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Table 48 South America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Figure 4 Global AI for Drug Discovery and Development Revenue Market Share (%) By Type (2022)

Figure 5 Global AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global AI for Drug Discovery and Development Revenue Market Share (%) By Applications (2022)

Figure 7 Global AI for Drug Discovery and Development Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global AI for Drug Discovery and Development Market Share (%) By Regions (2022)

Figure 9 North America AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Figure 10 North America AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Figure 11 North America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America AI for Drug Discovery and Development Revenue (USD Million) By Country (2018-2022)

Figure 19 South America AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Figure 20 South America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Figure 25 Global AI for Drug Discovery and Development Revenue Market Share (%) By Type (2030)

Figure 26 Global AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global AI for Drug Discovery and Development Revenue Market Share (%) By Applications (2030)

Figure 28 Global AI for Drug Discovery and Development Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Figure 30 North America AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Figure 31 North America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America AI for Drug Discovery and Development Revenue (USD Million) By Country (2023-2030)

Figure 39 South America AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Figure 40 South America AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa AI for Drug Discovery and Development Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation